As of April 2024 Coherus BioSciences has a market cap of $0.24 Billion. This makes Coherus BioSciences the world's 6743th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.24 B | -34.2% |
2023 | $0.37 B | -39.8% |
2022 | $0.61 B | -49.73% |
2021 | $1.22 B | -2.13% |
2020 | $1.25 B | -1.16% |
2019 | $1.26 B | 104.96% |
2018 | $0.61 B | 19.62% |
2017 | $0.51 B | -57.95% |
2016 | $1.22 B | 37.21% |
2015 | $0.89 B | 65% |
2014 | $0.54 B |
On Apr 17th, 2024 the market cap of Coherus BioSciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Amgen AMGN | $142.40 B | 58,257.55% | ๐บ๐ธ USA |
Repligen
RGEN | $8.98 B | 3,583.66% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | $0.82 M | -99.66% | ๐บ๐ธ USA |
Arena Pharmaceuticals
ARNA | $6.16 B | 2,426.56% | ๐บ๐ธ USA |